Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desloratadine + Prednisolone vs Dexchlorpheniramine + Betamethasone in Pediatric Allergic Rhinitis
NCT01529229Phase 3Completed
- Sponsor
- EMS
- Start
- Nov 2013
- Primary completion
- Oct 2014
- Modality
- Orthosteric Ligands
01
Overview
Phase 3, randomised, double-blind trial of desloratadine and prednisolone in allergic rhinitis (AR) (2 arms), sponsored by EMS. Primary endpoint: Nasal Symptoms Score at 7 days. Started Nov 2013; status: completed.
02
Drugs
desloratadineprednisolone
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT01529229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01529229.